14159 Sustained improvements in itch, skin pain, and health-related quality of life through 5 years of treatment with ixekizumab in patients with moderate to severe plaque psoriasis
We describe patient-reported outcomes through 5 years of treatment in patients with moderate to severe plaque psoriasis.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Melinda Gooderham, Boni Elizabeth Elewski, Matthias Augustin, Lars Iversen, Hideshi Torii, Russel Burge, Baojin Zhu, Gaia Gallo, William Eastman, Peter Foley Source Type: research
More News: Academies | Ankylosing Spondylitis | Arthritis | Dermatology | Itchiness | Pain | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin